Invitation to Join Study on Microbiome and Autism from Stanford School of Medicine and Second Genome
We were asked to see if any parents out there might like to join a study on the MICROBIOME and AUTISM :
Researchers at Stanford University School of Medicine and the South San Francisco pharmaceutical company Second Genome Inc. have jointly received a $2.1 million grant to recruit subjects for a study exploring potential links between bacteria in the gut — known as the microbiome — and autism, the company announced Tuesday.
Researchers have long suspected, based on anecdotal evidence, that there may be a link between the microbiome and the severity of an autism diagnosis. There is limited data demonstrating the link in humans, but some studies indicate it may exist in lab mice.
Many children with autism have food allergies or gut conditions such as inflammatory bowel diseases, leading researchers to hypothesize that activity in the gut has a relationship to autism, said Dennis Wall, an associate professor of pediatrics at Stanford who is co-leading the study. With the new grant from the National Institutes of Health, the researchers will attempt to test that theory, so doctors can better diagnose and design therapies for people on the autism spectrum.
Here are the details - (uploading a video is optional)
We are looking for 100 families with two or more children, where:
- One child has a medical diagnosis of autism spectrum disorder and is between 2-7 years old,
- And another child without an autism diagnosis, who is no more than two years apart in age of the first child.
The study procedures include responding to an online behavioral and dietary survey, uploading a 3-minute home video, and collecting stool and saliva samples at home for each child. Everything is completed either online or in the home.
Would you be willing to send out this study information to your email listserv and/or post on your social media platforms (Facebook, Twitter, etc)? We only need 40 more families to participate and we are so excited to start analyzing the data!
Please see our most recent press release on SF Chronicle here, a KQED press release, our recruitment flyer attached, and our study website to sign up now! If you have any questions, please don’t hesitate to ask.
The M3 Team
I just want to add that Stanford is also making progress on PANDAS and PANS, in fact they do research on that as well and actually have a team of experts and immune therapies . But when you look at the AUTISM clinic there , it is dismal and archaic and has very little to do with the immune system, although we know that for many autism patients with moderate to severe symptoms, the immune system is key, as we see in this study, Pediatric autoimmune neuropsychiatric syndrome (PANS), developmental regression and autism.
Let¨s not forget these connections as well:
Figuring out whether PANS patients make antibodies against their own brains is perhaps the most important key to the disease’s mysteries. The research bears similarities to the discovery of anti-NMDA receptor encephalitis, and the path to that breakthrough may provide a road map of sorts for PANS researchers.
Much research shows the AUTISM connection to ANTI-NMDA RECEPTOR Encephalitis, too:
SO, parents, please let them know the paradigm for autism needs to change by joining in the research on the MICROBIOME.
Teresa Conrick is Science Editor for Age of Autism.